Gut Enzyme Discovery: Prebiotic Research Breakthrough
- A novel enzyme found in the human gut may unlock new avenues for improving gut health.
- Glycans, complex carbohydrate chains, play significant roles in biological processes.
- Masahiro Nakajima, an associate professor at the Tokyo University of Science, led a team that discovered the novel β-galactosidase enzyme in the bacterium Bacteroides xylanisolvens.
A groundbreaking discovery in gut enzyme research is set to revolutionize the understanding of prebiotics and their impact on human health. researchers have identified a novel enzyme in the human gut that targets a specific prebiotic compound, β-1,2-galactooligosaccharide, unlocking its potential to boost gut health. This enzyme, found in the bacterium Bacteroides xylanisolvens, plays a vital role in breaking down these complex glycans. The implications are meaningful, potentially leading to new prebiotic products and therapies and expanding our knowledge of glycans’ functionality. News Directory 3 is following this research closely. What innovative applications for this discovery will emerge,and what impact will this have? Discover what’s next for the future of gut health.
gut Enzyme Discovery Unlocks prebiotic Potential for Human Health
Updated June 18, 2025
A novel enzyme found in the human gut may unlock new avenues for improving gut health. The enzyme targets β-1,2-galactooligosaccharide, a sugar-like compound or glycan, with potential prebiotic properties. Identifying this enzyme is crucial for understanding and harnessing the full potential of these glycans.
Glycans, complex carbohydrate chains, play significant roles in biological processes. Galactosides, a type of glycan containing galactose, are found in plants, animals, and even some processed foods. Understanding how enzymes break down these galactosides is key to maximizing their health benefits.
Masahiro Nakajima, an associate professor at the Tokyo University of Science, led a team that discovered the novel β-galactosidase enzyme in the bacterium Bacteroides xylanisolvens. The enzyme specifically targets galactose-containing glycans, which may have prebiotic effects. The findings were published Jan. 16 in Communications Biology.
Nakajima said the discovery is significant because many glycans have unknown functionality. he added that the new enzyme could be used to synthesize large amounts of unique glycans with prebiotic properties that may benefit human health.
Researchers found that the Bxy_22780 gene in B. xylanisolvens encodes the novel β-galactosidase. Further analysis revealed the enzyme’s high specificity for galactooligosaccharides (GOS) with β-1,2-galactosidic linkages. X-ray diffraction studies showed how the enzyme binds to break down these specific sugar chains.
Nakajima said that β-1,2-galactooligosaccharides are rarely reported, and this discovery is a crucial step toward understanding their functions. He added that the enzyme could open new therapeutic avenues for treating diseases like Chagas disease.
What’s next
the discovery of Bxy_22780 could lead to the growth of innovative prebiotic products to enhance gut health and support digestive functions, offering new opportunities in the food and supplement industries.